Zenlabs Ethica Limited

₹26.98As of Sun 8 Nov 2026, 12:00 UTC
BSE:530697Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 3.91%
Div yield —
ROE (20.44%)
Drugs, Drug Proprietaries, and Druggists' Sundries
Beta (5Y) 0.21
PE TTM —
TSR TTM (9.83%)
Mkt cap ₹175.6M
ROIC 1.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹34
24.71%
(24.19%)
Hold 0|9|5|5|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.27
0.28
0.27
0.27
9.95%
5.14%
(5.32%)
(3.86%)
Revenue₹M
11.96
11.66
12.28
12.35
8.82%
2.90%
4.19%
1.66%
Peers (US$1.768M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.925
0.150
0.156
EBIT/Intx
0.748
1.034
1.058
Own earn%
(32.88)
(21.67)
(25.02)
Sh yield%
24.26
37.68
37.78
Owners
Insiders/Inst%
3.40
56.84
Short interest%
3.02
SBC / revenue%
1.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
15–25
$1 testx
—
Incr. ROIC%
5